Hamster preproglucagon contains the sequence of glucagon and two related peptides
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Glucagon is a 29-amino acid polypeptide hormone synthesized by the A cells of the endocrine pancreas. Its primary site of action is the liver where it stimulates glycogenolysis, gluconeogenesis and ketogenesis. In mammals, biosynthetic studies have shown that glucagon is derived from a precursor of molecular weight (Mr) approximately 18,000 which is five to six times larger than glucagon. Glucagon-containing polypeptides and immunoreactants of various sizes have also been described from stomach, intestine, brain and salivary gland. Here, we have determined the structure of hamster pancreatic preproglucagon from the sequence of its cDNA. This 180-amino acid precursor contains the sequence of glucagon and two glucagon-like polypeptides arranged in tandem. The precursor also contains the sequences of several non-pancreatic glucagon-containing polypeptides which suggests that, in mammals, both pancreatic and non-pancreatic glucagon and glucagon-containing polypeptides may be derived from a common precursor by tissue-specific processing. We have tentatively identified each of the glucagon-like immunoreactants which have been described with respect to the sequence of proglucagon and have proposed a scheme for the processing of pancreatic proglucagon.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, GIP-driven weight loss is synergistically enhanced by adjunct GLP-1R agonism47-49”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“This highlighted for the first time that supplemental GLP-1R/GIPR co-agonism could greatly outperform GLP-1R mono-agonism, to achieve greater weight loss and elicit further improvements in glucose homeostasis48.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“GIPR agonist treatment is equally effective in promoting weight loss in obese mice”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“MAR709 successfully completed Phase 1 clinical trials with good tolerability48,124,125, concomitant with a meaningful reduction in body weight and HbA1c levels in subjects with T2D48,125.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“There are two notable unimolecular GLP-1R/GIPR co-agonist peptides that have been preclinically and clinically most characterized to display enhanced glucose-lowering potential, superior weight loss and appetite suppression, when evaluated with comparable GLP-1R agonists.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in Enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 14,315
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 8,156
Atlas of protein sequence and structure
Chang, M.-Y., Dayhoff, M. O., Eck, R. V., & Sochard, M. R. (1965) · NASA Technical Reports Server (NASA) · Cited by 4,383
3′ Non-coding region sequences in eukaryotic messenger RNA
Proudfoot, N. J., & Brownlee, G. G. (1976) · Nature · doi:10.1038/263211a0 · Cited by 2,968
Deoxynucleoside phosphoramidites—A new class of key intermediates for deoxypolynucleotide synthesis
Beaucage, S. L., & Caruthers, M. H. (1981) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)90461-7 · Cited by 1,993
Atlas of Protein Sequence and Structure, 1966.
Hersh, R. T., Eck, R. V., & Dayhoff, M. O. (1967) · Systematic Zoology · doi:10.2307/2412074 · Cited by 1,779
Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused Acromegaly
Guillemin, R., Brazeau, P., Bohlen, P., Esch, F., Ling, N., & Wehrenberg, W. B. (1982) · Science · doi:10.1126/science.6812220 · Cited by 1,294
The sequence 5′-AAUAAA-3′ forms part of the recognition site for polyadenylation of late SV40 mRNAs
Fitzgerald, M. (1981) · Cell · doi:10.1016/0092-8674(81)90521-3 · Cited by 776
Primary structure of the human Met- and Leu-enkephalin precursor and its mRNA
Comb, M., Seeburg, P. H., Adelman, J., Eiden, L., & Herbert, E. (1982) · Nature · doi:10.1038/295663a0 · Cited by 679
Research works printed but not linked: 1
- Unger, R.H. & Orei, L. (eds) Glucagon. Physiology, Pathophysiology and Morphology of the Pancreatic A-Cell (Elsevier, New York, 1981).
Cited by
Items 201–300 of 645
Seino, S., Welsh, M., Bell, G. I., Chan, S. J., & Steiner, D. F. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)81429-6 · Cited by 64
Self-citationAlpha-cell paracrine signaling in the regulation of beta-cell insulin secretion
Holter, M. M., Saikia, M., & Cummings, B. P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.934775 · Cited by 63
Controlled release of biologics for the treatment of type 2 diabetes
Gilroy, C. A., Luginbuhl, K. M., & Chilkoti, A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.002 · Cited by 67
“Interest was spurred upon cloning and sequencing of the proglucagon gene in 1983[88].”
Chowen, J. A., de Fonseca, F. R., Álvarez, E., Navarro, M. A., García‐Segura, L. M., & Blázquez, E. (1999) · Neuropeptides · doi:10.1054/npep.1999.0757 · Cited by 70
POLLOCK, H. G., Hamilton, J. W., Rouse, J. B., Ebner, K. E., & Rawitch, A. B. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81581-8 · Cited by 66
Methods and Guidelines for Measurement of Glucagon in Plasma
Holst, J. J., & Albrechtsen, N. J. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215416 · Cited by 62
“Upon cloning of the gene encoding proglucagon [27,28], this concept was found to be correct, but the proglucagon sequence also revealed the presence of two additional glucagon-related sequences in the remaining part of the precursor, henceforth designated the glucagon-like peptides-1 and -2.”
BackgroundImmunohistochemical localization of glucagon-like peptide 1
Kauth, T., & Metz, J. (1987) · Histochemistry and Cell Biology · doi:10.1007/bf00500625 · Cited by 61
Philippe, J., Drucker, D. J., & Habener, J. F. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75713-5 · Cited by 63
The role of the Wnt signaling pathway in incretin hormone production and function
Chiang, Y., Ip, W., & Jin, T. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00273 · Cited by 63
“, 1977), followed by the identification of GLP-1 in the mid-1980’s (Bell et al., 1983b; Scott et al., 1983).”
BackgroundMeier, J. J., Gallwitz, B., & Nauck, M. A. (2003) · BioDrugs · doi:10.2165/00063030-200317020-00002 · Cited by 67
Pandey, S., Mangmool, S., & Parichatikanond, W. (2023) · Pharmaceuticals · doi:10.3390/ph16060836 · Cited by 56
“GLP-1 and GLP-2 were identified in hamsters and humans; however, GLP-1 is the main isoform that could stimulate insulin secretion upon diet i gestion [8,9].”
BackgroundThe entero-insular axis: implications for human metabolism
Ranganath, L. R. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.008 · Cited by 71
Intestinal hormones and growth factors: Effects on the small intestine
Drozdowski, L. A., & Thomson, A. B. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.385 · Cited by 63
Glucagon-like peptide-1 (7–36 amide): a potent glucagonostatic and insulinotropic hormone
Matsuyama, T., Komatsu, R., Namba, M., Watanabe, N., Itoh, H., & Tarui, S. (1988) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(88)80063-9 · Cited by 64
The discovery and development of GLP-1 based drugs that have revolutionized the treatment of obesity
Friedman, J. M. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2415550121 · Cited by 64
Figueiredo, C. P., Pamplona, F. A., Mazzuco, T. L., Aguiar, A. S., Walz, R., & Prediger, R. D. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833c8544 · Cited by 62
“%) with other members of this GPCR family: the glucagon and the GLP-1 receptors (Gremlich et al., 1995).”
BackgroundInfluentialInventing Liraglutide, a Glucagon-Like Peptide-1 Analogue, for the Treatment of Diabetes and Obesity
Knudsen, L. B. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00048 · Cited by 56
GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASH
Li, Q.-X., Gao, H., Guo, Y.-X., Wang, B.-Y., Hua, R.-X., Gao, L., Shang, H.-W., Lu, X., & Xu, J.-D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721198 · Cited by 56
Insulin inhibits glucagon secretion by the activation of PI3-kinase in In-R1-G9 cells
Kaneko, K. B., Shirotani, T., Araki, E., Matsumoto, K., Taguchi, T., Motoshima, H., Yoshizato, K., Kishikawa, H., & Shichiri, M. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00021-2 · Cited by 56
Glucagon-like Peptide-1 (GLP-1) and the Control of Glucose Metabolism in Mammals and Teleost Fish
Mojsov, S. (2000) · American Zoologist · doi:10.1668/0003-1569(2000)040[0246:glpgat]2.0.co;2 · Cited by 57
Shibasaki, Y., Kawakami, T., Kanazawa, Y., Akanuma, Y., & Takaku, F. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111973 · Cited by 56
Neumiller, J. J. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.08.013 · Cited by 59
Bariatric surgery and obesity: influence on the incretins
Laferrère, B. (2016) · International Journal of Obesity Supplements · doi:10.1038/ijosup.2016.8 · Cited by 57
Deacon, C. F., & Holst, J. J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00359-5 · Cited by 55
Gut hormones as pharmaceuticals
Holst, J. J. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00185-3 · Cited by 65
Drucker, D. J. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00136-2 · Cited by 65
Özyazgan, S., Kutluata, N., Afşar, S., Özdaş, Ş. B., & Akkan, A. G. (2005) · Pharmacology · doi:10.1159/000084277 · Cited by 55
Glucagon and Glucagon-Like Peptides 1 and 2
Holst, J. J. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2009_35 · Cited by 56
The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome
Drucker, D. J. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00016 · Cited by 51
Pang, J., Feng, J. N., Ling, W., & Jin, T. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.06.003 · Cited by 52
Appetite control after weight loss: what is the role of bloodborne peptides?
Doucet, É., & Cameron, J. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-019 · Cited by 51
Molecular Forms of Glucagon-Like Peptide-1 in Human Pancreas and Glucagonomas
UTTENTHEL, L. O., GHIGLIONE, M., GEORGE, S. K., BISHOP, A. E., POLAK, J. M., & BLOOM, S. R. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-3-472 · Cited by 51
Hasegawa, S., Terazono, K., Nata, K., Takada, T., Yamamoto, H., & Okamoto, H. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80779-i · Cited by 53
Riecken, E. O., Stallmach, A., Zeitz, M., Schulzke, J., Menge, H., & Gregor, M. (1989) · Gut · doi:10.1136/gut.30.11.1630 · Cited by 57
Glucagon‐Like Peptide‐1: Actions and Influence on Pancreatic Hormone Function
Davis, E., & Sandoval, D. A. (2020) · Comprehensive physiology · doi:10.1002/cphy.c190025 · Cited by 59
GLP-1R Activation by Liraglutide Promotes Breast Cancer Through NOX4/ROS/VEGF Pathway
Liu, Z., Duan, X., Yuan, M., Yu, J. Y., Hu, X., Han, X., Lan, L., Liu, B., Wang, Y., & Qin, J. (2021) · Life Sciences · doi:10.1016/j.lfs.2022.120370 · Cited by 55
Anomalies in the Endocrine Axes of the Guinea Pig: Relevance to Human Physiology and Disease*
Keightley, M.-C., & Fuller, P. J. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-1-30 · Cited by 59
Kreymann, B., Yiangou, Y., Kanse, S., Williams, G., Ghatei, M. A., & Bloom, S. R. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81008-1 · Cited by 51
Park, J. S., Kim, K. S., & Choi, H. J. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0106 · Cited by 58
“Subsequently, a study by Bell et al. [8] conducted cDNA analysis of prepro-glucagon in hamsters, which revealed that mammalian genes differ from those of anglerfish and identified two novel peptides, terming them glucagon-related peptides 1 and 2 (GLP-1, GLP-2).”
Glucagon‐like peptide‐1 receptor agonists for type 2 diabetes: A rational drug development
Ahrén, B. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.12911 · Cited by 48
Kim, Y., Rose, C. A., Liu, Y., Ozaki, Y., Datta, G., & Tu, A. T. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830819 · Cited by 49
Andrews, P., Hawke, D. H., Lee, T. D., Legesse, K., Noe, B., & Shively, J. E. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83886-3 · Cited by 48
Primary structure of glucagon from an elasmobranchian fish, Torpedo marmorata
Conlon, J. M., & Thim, L. (1985) · General and Comparative Endocrinology · doi:10.1016/0016-6480(85)90073-5 · Cited by 48
Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists
Choe, H. J., & Cho, Y. M. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.102 · Cited by 42
“In 1983, GLP-1 was found in the quest for the discovery of a glucagon gene [3].”
BackgroundHamid, Q. A., Bishop, A. E., Sikri, K. L., Varndell, I. M., Bloom, S. R., & Polak, J. M. (1986) · Histopathology · doi:10.1111/j.1365-2559.1986.tb02468.x · Cited by 47
Proglucagon Gene Expression and Posttranslational Processing in a Hamster Islet Cell Line*
DRUCKER, D. J., PHILIPPE, J., & MOJSOV, S. (1988) · Endocrinology · doi:10.1210/endo-123-4-1861 · Cited by 46
Insulinotropic glucagonlike peptide-I(7–37)/(7–36)amide A new incretin hormone
Fehmann, H.-C., & Habener, J. F. (1992) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(92)90165-w · Cited by 50
“Proglucagon (PG), encoded by a single gene containing six exons separated by five introns (Bell et al. 1983; Heinrich et al. 1984), is expressed in the intestinal L cells, the pancreatic A cells, and scattered neurons in the brainstem.”
BackgroundGastro-intestinal hormones GIP and GLP-1
Kieffer, T. J. (2004) · Annales d Endocrinologie · doi:10.1016/s0003-4266(04)95625-9 · Cited by 49
“Mammalian preproglucagons were subsequently cloned and the pancreatic and intestinal GRPs were termed glucagon-like peptides (GLPs) [4, 47].”
BackgroundThe Neuroendocrine System of the Gut
Sundler, F., Bouttcher, G., Ekblad, E., & Haukanson, R. (1989) · Acta Oncologica · doi:10.3109/02841868909111198 · Cited by 48
Hybridization Approaches to the Study of Neuropeptides
Schwartz, J. P., & Costa, E. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.001425 · Cited by 46
Intra-islet glucagon-like peptide 1
Fava, G. E., Dong, E. W., & Wu, H. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.05.016 · Cited by 45
“GLP-1 and its fellow proglucagon-derived peptide, GLP-2, are first identified during investigation of the gene encoding the glucagon precursor, proglucagon (Bell et al. 1983; Lopez et al. 1983; Lund, et al. 1982).”
BackgroundPancreatic .BETA.-cell signaling: toward better understanding of diabetes and its treatment
SEINO, S., SHIBASAKI, T., & MINAMI, K. (2010) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.86.563 · Cited by 42
Mora, F., Expósito, I., Sanz, B., & Blázquez, E. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90068-9 · Cited by 52
PHILIPPE, J., MOJSOV, S., DRUCKER, D. J., & HABENER, J. F. (1986) · Endocrinology · doi:10.1210/endo-119-6-2833 · Cited by 47
Conlon, J. M., Hansen, H. F., & Schwartz, T. W. (1985) · Regulatory Peptides · doi:10.1016/0167-0115(85)90203-4 · Cited by 44
Gradient expression of Cdx along the rat intestine throughout postnatal development
Freund, J., Boukamel, R., & Benazzouz, A. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80965-j · Cited by 44
de Graaf‐Roelfsema, E. (2013) · The Veterinary Journal · doi:10.1016/j.tvjl.2013.09.064 · Cited by 51
“In humans, GIP is secreted by K cells of the upper small intestine (Inagaki et al., 1989) while GLP-1 is produced from proglucagon and secreted by L cells mostly of the lower small intestine and colon (Bell et al., 1983).”
BackgroundGlucagon and Related Peptides in Fetal Rat Hypothalamusin Vivoandin Vitro*
Lui, E. Y. T., Asa, S. L., Drucker, D. J., Lee, Y. C., & BRUBAKER, P. L. (1990) · Endocrinology · doi:10.1210/endo-126-1-110 · Cited by 52
Characterization of two lignin peroxidase clones from Phanerochaete chrysosporium
Andrawis, A., Pease, E. A., Kuan, I., Holzbaur, E. L. F., & Tien, M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92363-2 · Cited by 43
Pleiotropic Actions of the Incretin Hormones
McIntosh, C. H. S., Widenmaier, S. B., & Kim, S. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00002-3 · Cited by 46
Dey, A., Lipkind, G. M., Rouillé, Y., Norrbom, C., Stein, J. M., Zhang, C., Carroll, R., & Steiner, D. F. (2004) · Endocrinology · doi:10.1210/en.2004-1118 · Cited by 43
Characterization of receptors for glucagon‐like peptide‐1(7–36) amide on rat lung membranes
Richter, G., Göke, R., Göke, B., & Arnold, R. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80292-q · Cited by 43
How glucagon-like is glucagon-like peptide-1?
Ghiglione, M., UTTENTHAL, L. O., George, S. K., & Bloom, S. R. (1984) · Diabetologia · doi:10.1007/bf00276976 · Cited by 42
“The nucleotide sequences of cDNA derived from hamster [1] and ox [2] glucagon mRNA and the human preproglucagon gene [3] show that pre-proglucagon contains two further glucagon-like peptides (GLP-1 and -2) C-terminal to the glucagon sequence.”
BackgroundLopez, L. C., Li, W., Frazier, M. L., Luo, C. C., & Saunders, G. F. (1984) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040322 · Cited by 42
Gastrointestinal Hormones and Their Targets
Rehfeld, J. F. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0897-4_7 · Cited by 45
“Deduction of its structure from cloned cDNA provided the first evidence or suggestion of separate bioactive peptide moieties from the same precursor due to the homologies between the sequences 33–61, 72–107, and 126– 158 [32].”
BackgroundProglucagon-derived peptides: nomenclature, biosynthetic relationships and physiological roles
Conlon, J. M. (1988) · Diabetologia · doi:10.1007/bf00264761 · Cited by 42
“Cloning and sequence analysis of cDNAs and DNA fragments from genomic libraries has led to the elucidation of the primary structure of the biosynthetic precursor of glucagon (pre-proglucagon) from a variety of species including man [1-6].”
BackgroundHansen, A. B., Gespach, C. P., Rosselin, G. E., & Holst, J. J. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80297-7 · Cited by 41
Molecular cloning and characterization of cDNA for insect biogenic peptide, growth‐blocking peptide
Hayakawa, Y., Ohnishi, A., Yamanaka, A., Izumi, S., & Tomino, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01273-7 · Cited by 41
Dachicourt, N., Serradas, P., Bailbé, D., Kergoat, M., Doaré, L., & Portha, B. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1550369 · Cited by 40
“Glucagon-like-peptide-1(7‐37) or its amidated form, GLP-1(7‐36)-amide (GLP-1), are products of posttranslational processing of proglucagon in the mammalian intestine ( Bell et al. 1983, Mojsov et al. 1986).”
BackgroundIslam, D., Zhang, N., Wang, P., Li, H., Brubaker, P. L., Gaisano, H. Y., Wang, Q., & Jin, T. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90419.2008 · Cited by 39
“THE PROGLUCAGON GENE (gcg) is expressed in the pancreatic islet -cells, intestinal endocrine L cells, and selected neurons in the brain (4, 5, 11, 21, 30).”
BackgroundSingular contributions of fish neuroendocrinology to mammalian regulatory peptide research
Conlon, J. M. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00172-5 · Cited by 39
Knudsen, L. B., Secher, A., Hecksher‐Sørensen, J., & Pyke, C. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12463 · Cited by 36
Glucagon-like peptide-1 does not have a role in hepatic carbohydrate metabolism
Ghiglione, M., Blázquez, E., UTTENTHAL, L. O., de Diego, J. G., Álvarez, E., George, S. K., & Bloom, S. R. (1985) · Diabetologia · doi:10.1007/bf00703137 · Cited by 39
“served be tween hams t e r [1], m a n [2], ox [3] and rat [4], p resen ts a h o m o l o g y o f 14 out o f the 29 residues compa rab le with g lucagon.”
Background7 Humoral regulation of intestinal adaptation
Taylor, R. G., & Fuller, P. J. (1994) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80230-7 · Cited by 41
Poretsky, E., Dressano, K., Weckwerth, P. R., Ruiz, M., Char, S. N., Shi, D., Abagyan, R. A., Yang, B., & Huffaker, A. (2020) · The Plant Journal · doi:10.1111/tpj.15022 · Cited by 41
Molecular determinants of glucagon receptor signaling
Unson, C. G. (2002) · Biopolymers · doi:10.1002/bip.10259 · Cited by 42
Fehmann, H. C., & Habener, J. F. (1992) · Endocrinology · doi:10.1210/endo.130.5.1374016 · Cited by 38
Conlon, J. M., Falkmer, S. E., & Thim, L. (1987) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1987.tb11001.x · Cited by 38
Neuroendocrine potential of the colon and rectum
Lluís, F., & Thompson, J. C. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90262-4 · Cited by 40
Jeppesen, P. B. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05779-0 · Cited by 39
Dalle, S., Fontés, G., Lajoix, A.-D., LeBrigand, L., Gross, R., Ribes, G., Dufour, M., Barry, L., LeNguyen, D., & Bataille, D. (2002) · Diabetes · doi:10.2337/diabetes.51.2.406 · Cited by 37
The gut and food intake: an update for surgeons
Näslund, E. B., Hellström, P. M., & Kral, J. G. (2001) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(01)80095-0 · Cited by 42
Green, B., Gault, V., Mooney, M., Irwin, N., Bailey, C., Harriott, P., Greer, B., Flatt, P., & O'Harte, F. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310529 · Cited by 36
“Glucagon-like peptide-1(7–36)amide (GLP-1) is produced in the L cells of the small intestine by the tissue-specific post-translational processing of the product of the proglucagon gene (Bell et al. 1983).”
BackgroundEizirik, D. L., Sandler, S., Ahnström, G., & Welsh, M. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90230-3 · Cited by 40
Madsen, O. D., Andersen, L. C., Michelsen, B. K., Owerbach, D., Larsson, L., Lernmark, Å., & Steiner, D. F. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6652 · Cited by 36
Gregor, M., Menge, H., Stössel, R., & Riecken, E. O. (1987) · Gut · doi:10.1136/gut.28.suppl.9 · Cited by 36
Solcia, E., Fiocca, R., Capella, C., Usellini, L., Sessa, F., Rindi, G., Schwartz, T. W., & Yanaihara, N. (1985) · Peptides · doi:10.1016/0196-9781(85)90378-x · Cited by 35
Richter, G., Göke, R., Göke, B., Schmidt, H., & Arnold, R. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80303-k · Cited by 35
Diversification of the functions of proglucagon and glucagon receptor genes in fish
Irwin, D. M., & Mojsov, S. (2018) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2018.03.003 · Cited by 34
Hytting-Andreasen, R., Balk-Møller, E., Hartmann, B., Pedersen, J., Windeløv, J. A., Holst, J. J., & Kissow, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198046 · Cited by 36
Naming progastrin-derived peptides
Rehfeld, J. F., Bundgaard, J. R., Goetze, J. P., Friis-Hansen, L. J., Hilsted, L., & Johnsen, A. H. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.03.006 · Cited by 34
Burcelin, R., ROLLAND, E., Dolci, W., GERMAIN, S., CARREL, V., & Thorens, B. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08510.x · Cited by 37
Yamato, E., Noma, Y., Tahara, Y., Ikegami, H., Yamamoto, Y., Cha, T., Yoneda, H., Ogihara, T., Ohboshi, C., Hirota, M., et al. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92041-w · Cited by 34
Structural requirements for biological activity of glucagon‐like peptide‐I
MOJSOV, S. (1992) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1992.tb00309.x · Cited by 33
Xu, Y., Xiang, W., Wang, Q. L., Cheng, N., Zhang, L., Huang, K., & Xu, W. (2017) · Scientific Reports · doi:10.1038/srep43453 · Cited by 33
Gut Hormones as Potential New Targets for Appetite Regulation and the Treatment of Obesity
Field, B. C. T., Wren, A., Cooke, D., & Bloom, S. R. (2008) · Drugs · doi:10.2165/00003495-200868020-00002 · Cited by 38
Brubaker, P. L., SO, D. C. Y., & Drucker, D. J. (1989) · Endocrinology · doi:10.1210/endo-124-6-3003 · Cited by 33
Glucagon‐like peptide‐1: modulator of β ‐cell dysfunction and death
Rondas, D., D'Hertog, W., Overbergh, L., & Mathieu, C. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12165 · Cited by 32
“Analysis of the structural identity of GLP-1 revealed that the peptide sequence of mammalian GLP-1 is identical in mice, rats and humans [14–16].”
BackgroundPotential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance
Sharma, A., Virmani, T., Sharma, A., Chhabra, V., Kumar, G., Pathak, K., & Alhalmi, A. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s369712 · Cited by 36
“As the intestinal hormone, glucagon-like peptide-1 (GLP-1) was discovered to be a DPP-4 substrate, the relationship between DPP-4 and glucose homeostasis was discovered.(64,65) GLP-1 role in managing glycemia was discovered in 1986(66) when this unknown peptide was discovered to have dramatic effects on the endocrine…”
BackgroundHumoral Factors in Intestinal Adaptation
Baksheev, L., & Fuller, P. J. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00307-6 · Cited by 32
Metadata
- Authors
- Bell, G. I., Santerre, R. F., & Mullenbach, G. T.
- Affiliations
- Eli Lilly (United States) (US)
- Venue
- Nature
- Published
- 1983-04
- Volume
- 302
- Issue
- 5910
- Pages
- 716-718
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2061274996
- Cited by
- 649
- References
- 35
- Citations by year
- 2026: 22 · 2025: 22 · 2024: 22 · 2023: 9 · 2022: 16 · 2021: 20 · 2020: 8 · 2019: 16 · 2018: 16 · 2017: 8 · 2016: 18 · 2015: 13 · 2014: 21 · 2013: 12 · 2012: 9
- FWCI
- 41.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- proglucagon, glucagon, hamster, pancreatic A cells, cDNA sequence, precursor processing
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Fishes, Glucagon, Cricetinae, Molecular Weight, Protein Precursors, RNA, Messenger, Species Specificity, Proglucagon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.